Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026)
Precision Biosciences (DTIL) posted quarterly Interest & Investment Income of $999000.0 for Q1 2026, down 24.49% year-over-year from $1.3 million in Q1 2025, and up 29.24% quarter-over-quarter from $773000.0 in Q4 2025.
Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Interest & Investment Income for 9 consecutive years, with $999000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 24.49% year-over-year to $999000.0; the TTM figure through Mar 2026 stood at $3.9 million (down 39.05% YoY), while the FY2025 annual figure was $4.2 million, down 37.32% from the prior year.
- Interest & Investment Income climbed to $999000.0 in Q1 2026 per DTIL's latest filing, from $773000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q1 2023 and bottomed at $172000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 2974.6% — and 2025, when it tumbled 48.26%.
- Precision Biosciences' Interest & Investment Income stood at $1.9 million in 2022, then retreated by 5.68% to $1.8 million in 2023, then decreased by 18.23% to $1.5 million in 2024, then sank by 48.26% to $773000.0 in 2025, then rose by 29.24% to $999000.0 in 2026.
- Business Quant data shows DTIL's Interest & Investment Income at $999000.0 in Q1 2026, $773000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - | 943,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 943,000.00 |
| Mar 31, 2026 | 999,000.00 |
| Dec 31, 2025 | 773,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 44,000.00 |